This hypertrophy method was one of the late Charles Poliquin’s favourite muscle-building techniques and for good reason ...
New research proves the benefits of strength training for running economy – so here’s how to make the most of your ...
Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
“The last thing a presbyopic patient wants is to abandon their reading glasses and walk around with cosmetically red eyes,” Donnenfeld noted. “In BRIO-II, the rate of reported adverse events of ocular ...
The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient demand for noninvasive, reversible options to manage presbyopia,” Behnaz ...
Toray Industries has developed a piezoelectric polymer with heat resistance exceeding 200°C. The company's survey of ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
A start-up claims dream communication is possible, but scientists say sleeping brains interaction remains unproven and speculative.
Parkinson's disease is degenerative neurological disorder that primarily affects movement due to damage to dopamine-producing nerve cells ...
Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results